Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Long-Term Deferred Tax: 2023-2024

Historic Long-Term Deferred Tax for Sunshine Biopharma (SBFM) over the last 2 years, with Dec 2024 value amounting to $92,234.

  • Sunshine Biopharma's Long-Term Deferred Tax was N/A to $92,234 in Q3 2025 from the same period last year, while for Sep 2025 it was $92,234, marking a year-over-year change of. This contributed to the annual value of $92,234 for FY2024, which is 47.82% down from last year.
  • Sunshine Biopharma's Long-Term Deferred Tax amounted to $92,234 in FY2024, which was down 47.82% from $176,764 recorded in FY2023.
  • Sunshine Biopharma's Long-Term Deferred Tax's 5-year high stood at $176,764 during FY2023, with a 5-year trough of $92,234 in FY2024.
  • For the 2-year period, Sunshine Biopharma's Long-Term Deferred Tax averaged around $134,499, with its median value being $134,499 (2023).
  • Data for Sunshine Biopharma's Long-Term Deferred Tax shows a maximum YoY plummeted of 47.82% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows Sunshine Biopharma's Long-Term Deferred Tax stood at $176,764 in 2023, then plummeted by 47.82% to $92,234 in 2024.